Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia Using Text Messages
Sponsor: University of Chicago
This NA trial investigates Acute Lymphoblastic Leukemia and is currently actively recruiting participants. University of Chicago leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Mar 2026 — Present [monthly]
Not Yet Recruiting NA
-
Jan 2026 — Mar 2026 [monthly]
Not Yet Recruiting NA
-
Feb 2025 — Jan 2026 [monthly]
Not Yet Recruiting NA
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .